Jack W O'Sullivan1, Anna Shcherbina2,3, Johanne M Justesen3, Mintu Turakhia1,4,5, Marco Perez1, Hannah Wand1, Catherine Tcheandjieu1, Shoa L Clarke1, Manuel A Rivas3, Euan A Ashley1,6,3. 1. Division of Cardiology, Department of Medicine (J.W.O., M.T., M.P., H.W., C.T., S.L.C., E.A.A.), Stanford University School of Medicine, Stanford, CA. 2. Department of Biomedical Data Science (A.S.), Stanford University School of Medicine, Stanford, CA. 3. Department of Biomedical Data Science, Stanford University, Stanford, CA (A.S., J.M.J., M.A.R., E.A.A.). 4. Center for Digital Health (M.T.), Stanford University School of Medicine, Stanford, CA. 5. Veterans Affairs Palo Alto Health Care System, Palo Alto, CA (M.T.). 6. Department of Genetics (E.A.A.), Stanford University School of Medicine, Stanford, CA.
Abstract
BACKGROUND: Atrial fibrillation (AF) is associated with a five-fold increased risk of ischemic stroke. A portion of this risk is heritable; however, current risk stratification tools (CHA2DS2-VASc) do not include family history or genetic risk. We hypothesized that we could improve ischemic stroke prediction in patients with AF by incorporating polygenic risk scores (PRS). METHODS: Using data from the largest available genome-wide association study in Europeans, we combined over half a million genetic variants to construct a PRS to predict ischemic stroke in patients with AF. We externally validated this PRS in independent data from the UK Biobank, both independently and integrated with clinical risk factors. The integrated PRS and clinical risk factors risk tool had the greatest predictive ability. RESULTS: Compared with the currently recommended risk tool (CHA2DS2-VASc), the integrated tool significantly improved Net Reclassification Index (2.3% [95% CI, 1.3%-3.0%]) and fit (χ2 P=0.002). Using this improved tool, >115 000 people with AF would have improved risk classification in the United States. Independently, PRS was a significant predictor of ischemic stroke in patients with AF prospectively (hazard ratio, 1.13 per 1 SD [95% CI, 1.06-1.23]). Lastly, polygenic risk scores were uncorrelated with clinical risk factors (Pearson correlation coefficient, -0.018). CONCLUSIONS: In patients with AF, there appears to be a significant association between PRS and risk of ischemic stroke. The greatest predictive ability was found with the integration of PRS and clinical risk factors; however, the prediction of stroke remains challenging.
BACKGROUND: Atrial fibrillation (AF) is associated with a five-fold increased risk of ischemic stroke. A portion of this risk is heritable; however, current risk stratification tools (CHA2DS2-VASc) do not include family history or genetic risk. We hypothesized that we could improve ischemic stroke prediction in patients with AF by incorporating polygenic risk scores (PRS). METHODS: Using data from the largest available genome-wide association study in Europeans, we combined over half a million genetic variants to construct a PRS to predict ischemic stroke in patients with AF. We externally validated this PRS in independent data from the UK Biobank, both independently and integrated with clinical risk factors. The integrated PRS and clinical risk factors risk tool had the greatest predictive ability. RESULTS: Compared with the currently recommended risk tool (CHA2DS2-VASc), the integrated tool significantly improved Net Reclassification Index (2.3% [95% CI, 1.3%-3.0%]) and fit (χ2 P=0.002). Using this improved tool, >115 000 people with AF would have improved risk classification in the United States. Independently, PRS was a significant predictor of ischemic stroke in patients with AF prospectively (hazard ratio, 1.13 per 1 SD [95% CI, 1.06-1.23]). Lastly, polygenic risk scores were uncorrelated with clinical risk factors (Pearson correlation coefficient, -0.018). CONCLUSIONS: In patients with AF, there appears to be a significant association between PRS and risk of ischemic stroke. The greatest predictive ability was found with the integration of PRS and clinical risk factors; however, the prediction of stroke remains challenging.
Authors: Euan A Ashley; Atul J Butte; Matthew T Wheeler; Rong Chen; Teri E Klein; Frederick E Dewey; Joel T Dudley; Kelly E Ormond; Aleksandra Pavlovic; Alexander A Morgan; Dmitry Pushkarev; Norma F Neff; Louanne Hudgins; Li Gong; Laura M Hodges; Dorit S Berlin; Caroline F Thorn; Katrin Sangkuhl; Joan M Hebert; Mark Woon; Hersh Sagreiya; Ryan Whaley; Joshua W Knowles; Michael F Chou; Joseph V Thakuria; Abraham M Rosenbaum; Alexander Wait Zaranek; George M Church; Henry T Greely; Stephen R Quake; Russ B Altman Journal: Lancet Date: 2010-05-01 Impact factor: 79.321
Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castellá; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas Journal: Rev Esp Cardiol (Engl Ed) Date: 2017-01
Authors: Frederick E Dewey; Megan E Grove; Cuiping Pan; Benjamin A Goldstein; Jonathan A Bernstein; Hassan Chaib; Jason D Merker; Rachel L Goldfeder; Gregory M Enns; Sean P David; Neda Pakdaman; Kelly E Ormond; Colleen Caleshu; Kerry Kingham; Teri E Klein; Michelle Whirl-Carrillo; Kenneth Sakamoto; Matthew T Wheeler; Atul J Butte; James M Ford; Linda Boxer; John P A Ioannidis; Alan C Yeung; Russ B Altman; Themistocles L Assimes; Michael Snyder; Euan A Ashley; Thomas Quertermous Journal: JAMA Date: 2014-03-12 Impact factor: 56.272
Authors: Vincent Plagnol; Peter Donnelly; Fernando Riveros-Mckay; Michael E Weale; Rachel Moore; Saskia Selzam; Eva Krapohl; R Michael Sivley; William A Tarran; Peter Sørensen; Alexander S Lachapelle; Jonathan A Griffiths; Ayden Saffari; John Deanfield; Chris C A Spencer; Julia Hippisley-Cox; David J Hunter; Jack W O'Sullivan; Euan A Ashley Journal: Circ Genom Precis Med Date: 2021-03-02
Authors: Hannah Wand; Samuel A Lambert; Cecelia Tamburro; Michael A Iacocca; Jack W O'Sullivan; Catherine Sillari; Iftikhar J Kullo; Robb Rowley; Jacqueline S Dron; Deanna Brockman; Eric Venner; Mark I McCarthy; Antonis C Antoniou; Douglas F Easton; Robert A Hegele; Amit V Khera; Nilanjan Chatterjee; Charles Kooperberg; Karen Edwards; Katherine Vlessis; Kim Kinnear; John N Danesh; Helen Parkinson; Erin M Ramos; Megan C Roberts; Kelly E Ormond; Muin J Khoury; A Cecile J W Janssens; Katrina A B Goddard; Peter Kraft; Jaqueline A L MacArthur; Michael Inouye; Genevieve L Wojcik Journal: Nature Date: 2021-03-10 Impact factor: 69.504
Authors: Steve Bevan; Matthew Traylor; Poneh Adib-Samii; Rainer Malik; Nicola L M Paul; Caroline Jackson; Martin Farrall; Peter M Rothwell; Cathie Sudlow; Martin Dichgans; Hugh S Markus Journal: Stroke Date: 2012-10-04 Impact factor: 7.914
Authors: Loes Ca Rutten-Jacobs; Susanna C Larsson; Rainer Malik; Kristiina Rannikmäe; Cathie L Sudlow; Martin Dichgans; Hugh S Markus; Matthew Traylor Journal: BMJ Date: 2018-10-24
Authors: Jack W O'Sullivan; Sam Grigg; William Crawford; Mintu P Turakhia; Marco Perez; Erik Ingelsson; Matthew T Wheeler; John P A Ioannidis; Euan A Ashley Journal: JAMA Netw Open Date: 2020-04-01